A scatter plot analysis revealed a significant positive correlation between FZD2 and tumor purity in three cancers (GBM, THYM, TGCT) and a negative correlation in 16 cancers, including LUAD, COAD, BRCA, STES, STAD, and PRAD (Figure 8B). Here, FZD2 is linked to glioblastoma.